Cargando…
Association between different anticholinergic drugs and subsequent dementia risk in patients with diabetes mellitus
BACKGROUND: The effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with diabetes mellitus (DM) remain unknown. We investigated the effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with DM. METHODS: We conducted a cohort study by using the d...
Autores principales: | Yang, Yu-Wan, Liu, Hsin-Ho, Lin, Tien-Huang, Chuang, Hsun-Yang, Hsieh, Tengfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383287/ https://www.ncbi.nlm.nih.gov/pubmed/28384267 http://dx.doi.org/10.1371/journal.pone.0175335 |
Ejemplares similares
-
Anticholinergic drugs and risk of dementia: Time for action?
por: Bell, Brian, et al.
Publicado: (2021) -
Anticholinergic drugs and risk of dementia: case-control study
por: Richardson, Kathryn, et al.
Publicado: (2018) -
Anticholinergic drugs and risk of dementia: case-control study
Publicado: (2019) -
Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2022) -
Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2021)